Bharat Parenterals Limited (BOM:541096)
India · Delayed Price · Currency is INR 1,315.60
-33.85 (-2.51%)
At close: Aug 17, 2026
Bharat Parenterals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,232 | 3,454 | 3,404 | 2,612 | 2,193 | 2,123 |
Revenue Growth | -11.19% | 1.48% | 30.31% | 19.11% | 3.28% | 2.46% |
Gross Profit Gross Profit Growth | 1,543 | 1,540 | 1,508 | 998.57 | 799.43 | 744.1 |
Operating Income Operating Income Growth | -237.58 | -184.34 | -311.49 | 182.69 | 198.33 | 244.99 |
Net Income Net Income Growth | -154.07 | -81.88 | -126.26 | 145.17 | 157.15 | 213.04 |
Earnings Per Share EPS Growth | - | -20.22 | -19.26 | 24.94 | 27.21 | 37.11 |
EPS Growth | - | - | - | -8.37% | -26.67% | 4.29% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Trading Of Pharma Products Trading Of Pharma Products Growth | 621.57 | - | - | - | - |
Contract Development And Manufacturing Operations Contract Development And Manufacturing Operations Growth | 723.09 | - | - | - | - |
Manufacturing Of Pharma Products Manufacturing Of Pharma Products Growth | 2,110 | - | - | - | - |
Pharmaceuticals Pharmaceuticals Growth | - | 3,404 | 2,612 | 2,193 | 2,123 |
Total Total Growth | 3,454 | 3,404 | 2,612 | 2,193 | 2,123 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 169.31 | 169.31 | 442.9 | 492.25 | 89.28 | 349.02 |
Total Debt Total Debt Growth | 1,461 | 1,461 | 1,802 | 1,576 | 497.45 | 177.46 |
Net Cash (Debt) Net Cash Growth | -1,292 | -1,292 | -1,359 | -1,084 | -408.16 | 171.56 |
Net Cash Growth | - | - | - | - | - | -46.79% |
Net Cash Per Share Net Cash Per Share Growth | - | -318.95 | -207.37 | -186.12 | -70.68 | 29.89 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 383.62 | -272.54 | -47.06 | 216.64 | -220.75 |
Capital Expenditures CapEx Growth | - | -399.33 | -290.76 | -1,043 | -916.01 | -47.63 |
Free Cash Flow Free Cash Flow Growth | - | -15.71 | -563.3 | -1,090 | -699.37 | -268.38 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 47.75% | 44.59% | 44.32% | 38.23% | 36.45% | 35.04% |
Operating Margin | -7.35% | -5.34% | -9.15% | 6.99% | 9.04% | 11.54% |
Pretax Margin | -7.88% | -6.20% | -9.97% | 7.17% | 10.74% | 13.36% |
Profit Margin | -4.77% | -2.37% | -3.71% | 5.56% | 7.17% | 10.03% |
FCF Margin | - | -0.46% | -16.55% | -41.73% | -31.89% | -12.64% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 1.000 | 1.000 | 0.750 |
Dividend Per Share Growth | -42.86% | 0% | 0% | 33.33% | - |
Dividend Yield | 0.07% | 0.11% | 0.10% | 0.09% | 0.22% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | 44.99 | 12.35 | 9.25 |
PS Ratio | 2.81 | 1.80 | 1.89 | 2.50 | 0.89 | 0.93 |